Atlas Trials

Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma

Clinical trial NCT06562673 · COMPLETED

Trial details

NCT number
NCT06562673
Sponsor
Shanghai 6th People's Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
OsteosarcomaBone Cancer
Start date
2024-12-03
Primary completion
2025-04-17
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.